Virbac SA

Carros, France

Virbac SA

Carros, France
SEARCH FILTERS
Time filter
Source Type

This report studies Animal Parasiticides in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Bayer Zoetis Sanofi Boehringer Ingelheim Merck & Co. Novartis AG Ceva Sante Animale ELI Lilly and Company Virbac Perrigo Company Vetoquinol For more information or any query mail at sales@wiseguyreports.com By types, the market can be split into Oral Liquids Tablets Injectables Sprays Other By Application, the market can be split into Animal Home Care By Regions, this report covers (we can add the regions/countries as you want) North America China Europe Southeast Asia Japan India Global Animal Parasiticides Market Professional Survey Report 2017 1 Industry Overview of Animal Parasiticides 1.1 Definition and Specifications of Animal Parasiticides 1.1.1 Definition of Animal Parasiticides 1.1.2 Specifications of Animal Parasiticides 1.2 Classification of Animal Parasiticides 1.2.1 Oral Liquids 1.2.2 Tablets 1.2.3 Injectables 1.2.4 Sprays 1.2.5 Other 1.3 Applications of Animal Parasiticides 1.3.1 Animal 1.3.2 Home Care 1.3.3 Application 3 1.4 Market Segment by Regions 1.4.1 North America 1.4.2 China 1.4.3 Europe 1.4.4 Southeast Asia 1.4.5 Japan 1.4.6 India 2 Manufacturing Cost Structure Analysis of Animal Parasiticides 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Animal Parasiticides 2.3 Manufacturing Process Analysis of Animal Parasiticides 2.4 Industry Chain Structure of Animal Parasiticides 8 Major Manufacturers Analysis of Animal Parasiticides 8.1 Bayer 8.1.1 Company Profile 8.1.2 Product Picture and Specifications 8.1.2.1 Product A 8.1.2.2 Product B 8.1.3 Bayer 2016 Animal Parasiticides Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.1.4 Bayer 2016 Animal Parasiticides Business Region Distribution Analysis 8.2 Zoetis 8.2.1 Company Profile 8.2.2 Product Picture and Specifications 8.2.2.1 Product A 8.2.2.2 Product B 8.2.3 Zoetis 2016 Animal Parasiticides Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.2.4 Zoetis 2016 Animal Parasiticides Business Region Distribution Analysis 8.3 Sanofi 8.3.1 Company Profile 8.3.2 Product Picture and Specifications 8.3.2.1 Product A 8.3.2.2 Product B 8.3.3 Sanofi 2016 Animal Parasiticides Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.3.4 Sanofi 2016 Animal Parasiticides Business Region Distribution Analysis 8.4 Boehringer Ingelheim 8.4.1 Company Profile 8.4.2 Product Picture and Specifications 8.4.2.1 Product A 8.4.2.2 Product B 8.4.3 Boehringer Ingelheim 2016 Animal Parasiticides Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.4.4 Boehringer Ingelheim 2016 Animal Parasiticides Business Region Distribution Analysis 8.5 Merck & Co. 8.5.1 Company Profile 8.5.2 Product Picture and Specifications 8.5.2.1 Product A 8.5.2.2 Product B 8.5.3 Merck & Co. 2016 Animal Parasiticides Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.5.4 Merck & Co. 2016 Animal Parasiticides Business Region Distribution Analysis 8.6 Novartis AG 8.6.1 Company Profile 8.6.2 Product Picture and Specifications 8.6.2.1 Product A 8.6.2.2 Product B 8.6.3 Novartis AG 2016 Animal Parasiticides Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.6.4 Novartis AG 2016 Animal Parasiticides Business Region Distribution Analysis 8.7 Ceva Sante Animale 8.7.1 Company Profile 8.7.2 Product Picture and Specifications 8.7.2.1 Product A 8.7.2.2 Product B 8.7.3 Ceva Sante Animale 2016 Animal Parasiticides Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.7.4 Ceva Sante Animale 2016 Animal Parasiticides Business Region Distribution Analysis 8.8 ELI Lilly and Company 8.8.1 Company Profile 8.8.2 Product Picture and Specifications 8.8.2.1 Product A 8.8.2.2 Product B 8.8.3 ELI Lilly and Company 2016 Animal Parasiticides Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.8.4 ELI Lilly and Company 2016 Animal Parasiticides Business Region Distribution Analysis For more information or any query mail at sales@wiseguyreports.com ABOUT US: Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of rmaket research reports under these categories and sub-categories. For more information, please visit https://www.wiseguyreports.com


Receive press releases from iHealthcareAnalyst, Inc.: By Email Bovine Respiratory Disease Treatment Market by Diseases, Treatment, End Users and Forecast to 2021, Upcoming Report by iHealthcareAnalyst, Inc. Bovine Respiratory Disease Treatment Market by Disease Type (Diphtheria, Pneumonia/Lower Respiratory Tract Infection, Upper Respiratory Tract Infections), Treatment Type (Antibiotics, Immunomodulators, NSAIDs, Vaccines, Others), and End Users (Private Veterinary Pharmacies, Veterinary Clinics, Veterinary Hospitals, Veterinary Research Institutes, Others) and Forecast 2017-2021 Maryland Heights, MO, May 11, 2017 --( Visit Bovine Respiratory Disease Treatment Market by Disease Type (Diphtheria, Pneumonia/Lower Respiratory Tract Infection, Upper Respiratory Tract Infections), Treatment Type (Antibiotics, Immunomodulators, NSAIDs, Vaccines, Others), and End Users (Private Veterinary Pharmacies, Veterinary Clinics, Veterinary Hospitals, Veterinary Research Institutes, Others) and Forecast 2017-2021 at https://www.ihealthcareanalyst.com/report/bovine-respiratory-disease-treatment-market/ The global bovine respiratory disease treatment market segmentation is based on disease type (diphtheria, pneumonia/lower respiratory tract infection, upper respiratory tract infections), treatment type (antibiotics, immunomodulators, NSAIDs, vaccines, others), and end users (private veterinary pharmacies, veterinary clinics, veterinary hospitals, veterinary research institutes, others). The global bovine respiratory disease treatment market report provides market size (Revenue USD Million 2014 to 2021), market share, trends and forecasts growth trends (CAGR%, 2017 to 2021). The global bovine respiratory disease treatment market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global bovine respiratory disease treatment market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market by company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market. Major players operating in the global bovine respiratory disease treatment market and included in this report are Bayer AG, Bimeda Animal Health, Boehringer Ingelheim GmbH, Ceva, Elanco, Merck and Co., Inc., Merial, Vetoquinol, Virbac Group, and Zoetis Services LLC. 1. Disease Type 1.1. Diphtheria 1.2. Pneumonia (Lower Respiratory Tract Infection) 1.3. Upper Respiratory Tract Infections 2. Treatment Type 2.1. Antibiotics 2.2. Immunomodulators 2.3. NSAIDs 2.4. Vaccines 2.5. Others 3. End User 3.1. Private Veterinary Pharmacies 3.2. Veterinary Clinics 3.3. Veterinary Hospitals 3.4. Veterinary Research Institutes 3.5. Others 4. Company Profiles 4.1. Bayer AG 4.2. Bimeda Animal Health 4.3. Boehringer Ingelheim GmbH 4.4. Ceva 4.5. Elanco 4.6. Merck and Co., Inc. 4.7. Merial 4.8. Vetoquinol 4.9. Virbac Group 4.10. Zoetis Services LLC To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/bovine-respiratory-disease-treatment-market/ About Us iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals. In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study. Contact Us iHealthcareAnalyst, Inc. 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043 United States Email: sales@ihealthcareanalyst.com Website: https://www.ihealthcareanalyst.com Maryland Heights, MO, May 11, 2017 --( PR.com )-- Bovine respiratory disease (BRD) is the most common and costly disease affecting beef cattle in the world. BRD in cattle caused by a range of factors, singly or in combination. A major cause of economic losses, BRD affects the lower respiratory tract / lungs (pneumonia) or upper respiratory tract (rhinitis, tracheitis, bronchitis). It is a complex, bacterial infection that causes pneumonia in calves and can possibly be fatal. The infection is usually a sum of three codependent factors: Stress, an underlying viral infection, and a new bacterial infection. BRD is a "multi-factorial syndrome" that is dependent on a number of different causes. The bacterial agents most commonly linked with BRD are Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis. Viral agents include Bovine Viral Diarrhea (BVD), Infectious Bovine Rhinotracheitis (IBR), Bovine Respiratory Synctial Virus (BRSV), and Parainfluenza Type-3 Virus (PI-3). Antibiotics such as Micotil, Nuflor, and Baytril 100, Naxcel, Excenel, and Adspec can help to stop the bacterial factors of the disease. Vaccines are available for a number of viral/bacterial agents, including IBR, PI3, BVD, BRSV, Pasteurella, and Haemophilius somnus. Banamine is an anti-inflammatory drug which helps reduce fever and damage to the lungs, and therefore may help sick calves get back on feed quicker. Vitamin B and Probiotics can be used to help stimulate appetite.Visit Bovine Respiratory Disease Treatment Market by Disease Type (Diphtheria, Pneumonia/Lower Respiratory Tract Infection, Upper Respiratory Tract Infections), Treatment Type (Antibiotics, Immunomodulators, NSAIDs, Vaccines, Others), and End Users (Private Veterinary Pharmacies, Veterinary Clinics, Veterinary Hospitals, Veterinary Research Institutes, Others) and Forecast 2017-2021 at https://www.ihealthcareanalyst.com/report/bovine-respiratory-disease-treatment-market/The global bovine respiratory disease treatment market segmentation is based on disease type (diphtheria, pneumonia/lower respiratory tract infection, upper respiratory tract infections), treatment type (antibiotics, immunomodulators, NSAIDs, vaccines, others), and end users (private veterinary pharmacies, veterinary clinics, veterinary hospitals, veterinary research institutes, others).The global bovine respiratory disease treatment market report provides market size (Revenue USD Million 2014 to 2021), market share, trends and forecasts growth trends (CAGR%, 2017 to 2021). The global bovine respiratory disease treatment market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global bovine respiratory disease treatment market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market by company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market.Major players operating in the global bovine respiratory disease treatment market and included in this report are Bayer AG, Bimeda Animal Health, Boehringer Ingelheim GmbH, Ceva, Elanco, Merck and Co., Inc., Merial, Vetoquinol, Virbac Group, and Zoetis Services LLC.1. Disease Type1.1. Diphtheria1.2. Pneumonia (Lower Respiratory Tract Infection)1.3. Upper Respiratory Tract Infections2. Treatment Type2.1. Antibiotics2.2. Immunomodulators2.3. NSAIDs2.4. Vaccines2.5. Others3. End User3.1. Private Veterinary Pharmacies3.2. Veterinary Clinics3.3. Veterinary Hospitals3.4. Veterinary Research Institutes3.5. Others4. Company Profiles4.1. Bayer AG4.2. Bimeda Animal Health4.3. Boehringer Ingelheim GmbH4.4. Ceva4.5. Elanco4.6. Merck and Co., Inc.4.7. Merial4.8. Vetoquinol4.9. Virbac Group4.10. Zoetis Services LLCTo request Table of Contents and Sample Pages of this report visit:https://www.ihealthcareanalyst.com/report/bovine-respiratory-disease-treatment-market/About UsiHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.Contact UsiHealthcareAnalyst, Inc.2109, Mckelvey Hill Drive,Maryland Heights, MO 63043United StatesEmail: sales@ihealthcareanalyst.comWebsite: https://www.ihealthcareanalyst.com Click here to view the list of recent Press Releases from iHealthcareAnalyst, Inc.


LONDON, May 11, 2017 /PRNewswire/ -- India Animal Health Care Market: Overview In terms of revenue, the India animal health care market is expected to register a CAGR of 8.0% during the forecast period, 2016–2024. The primary objective of the report is to offer insights on the market dynamics that can influence growth of the India animal health care market over the forecast period. Insights on key trends, drivers, restraints, value forecasts and opportunities for companies operating in the India animal health care market are presented in the report. Download the full report: https://www.reportbuyer.com/product/4895311/ The India animal health care market is expected to witness significant growth rate in terms of value owing to Increase in consumption of animal protein among human population, rise in epidemics of animal diseases, significant animal population and better technology and growing awareness about animal health management practices contributes to growth of the animal health care market. Moreover, development of novel drugs and vaccines against various animal diseases is creating high potential growth opportunities for players operating in the India animal health care market. Revenue from the animal health care market in India is expected to expand at the relatively higher CAGR due to rising awareness for veterinary care and development of strong distribution channel in India. To understand and assess opportunities in this market, the report offers market forecast on the basis of animal type, therapeutic applications and zones. The report provides analysis of the India animal health care market in terms of market value (US$ Mn). India Animal Health Care Market: Segmentation The India animal health care market is segmented on the basis of animal type: Livestock and Companion. The report begins with the market definition, followed by definitions of the different animal types and different therapeutic applications. The market dynamics section includes TMR's analysis on key trends, drivers, restraints, opportunities and macro-economic factors influencing the growth of the India animal health care market. Next, the report analyses the market on the basis of regions and presents forecast in terms of value for the next 10 years. On the basis of zone, the India animal health care market is segmented into North India, East India, West India, and South India. We have considered Year-on-Year (Y-o-Y) growth to understand the predictability of the market and identify growth opportunities for companies operating in the India animal health care market. Another key feature of this report is the analysis of key segments in terms of absolute dollar opportunity. This is usually overlooked, while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective for services offered by animal health care market. To understand key segments in terms of their growth and performance in the India animal health care market, Transparency market research has developed a market attractiveness index. The resulting index would help providers identify existing market opportunities. India Animal Health Care Market: Competitive Analysis In the final section of the report, a 'competitive landscape' has been included to provide a dashboard view of key companies operating in the India animal health care market. This section is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment in the India animal health care market and the potential players. However, this section also includes market strategies and SWOT analysis of the main players operational in the India animal health care market. Detailed profiles of players operating in India animal health care market are also included in the scope of the report to evaluate their long- and short-term strategies. Key players included in this report are Merck & Co., Inc. (Intervet India Pvt. Ltd.), Zoetis, Inc., Bayer AG, Elanco, Merial, Boehringer Ingelheim GmbH, Virbac Group, Ceva Santé Animale, Vetoquinol, Intas Pharmaceuticals Ltd., Cipla, Inc. (Cipla Vet), Cargill, Incorporated, Venkys India, Zydus Animal Health, The Himalaya Drug Company, Ayurvet Limited, and Natural Remedies Pvt. Ltd., among others. The India animal health care market has been segmented as follows: By Zone North India East India West India South India By Animal Type Livestock Bovine Species Porcine Species Ovine Species Poultry Species Companion Canine Species Feline Species By Distribution Channel Veterinary Hospitals Veterinary Clinics Pharmacies and Drug Stores Others (Direct Distribution, Pet Shops) By Therapeutic Type Drugs Anti-infective by route of administration Analgesic, Antipyretic, and Anti-inflammatory by route of administration Parasiticides by route of administration Dewormers by route of administration Others by route of administration Vaccines Live Attenuated Vaccine by route of administration Inactivated Vaccine by route of administration Download the full report: https://www.reportbuyer.com/product/4895311/ About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers http://www.reportbuyer.com For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: query@reportbuyer.com Tel: +44 208 816 85 48 Website: www.reportbuyer.com To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/animal-health-care-market-and-companion-distribution-channel---veterinary-hospitals-veterinary-clinics-pharmacies-drug-stores-direct-distribution-and-pet-shops---india-industry-analysis-size-share-growth-trends-and-fore-300456382.html


News Article | May 9, 2017
Site: www.prnewswire.com

Technavio's analysts forecast the global veterinary vaccines market to grow at a CAGR of 4.81% during the period 2017-2021. Covered in this report The report covers the present scenario and the growth prospects of the global veterinary vaccines market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The market is divided into the following segments based on geography: • Americas • APAC • EMEA Technavio's report, Global Veterinary Vaccines Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors • Elanco • Merck • Merial • Zoetis Other prominent vendors • Advaxis • AmpliPhi Biosciences • Aratana Therapeutics • ARKO Labs • Bayer • CanFel Therapeutics • Ceva Animal Health • Colorado Serum Company • Epitopix • Genus • Hygieia Biological Laboratories • ImmuCell • Nexvet • Nuovo Biologics • UBI • Valneva • Vetoquinol • Virbac Market driver • Dependency on livestock products. • For a full, detailed list, view our report Market challenge • Manufacturing and storage issues. • For a full, detailed list, view our report Market trend • Robust R&D and improved product portfolio. • For a full, detailed list, view our report Key questions answered in this report • What will the market size be in 2021 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space? • What are the market opportunities and threats faced by the key vendors? • What are the strengths and weaknesses of the key vendors? You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report. Methodology Download the full report: https://www.reportbuyer.com/product/4886913/ About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers http://www.reportbuyer.com For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: query@reportbuyer.com Tel: +44 208 816 85 48 Website: www.reportbuyer.com To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-veterinary-vaccines-market-2017-2021-300453690.html


The invention relates to a topical veterinary composition for animals. It is characterized in that it comprises, in a physiologically acceptable medium, extracts of boldo Peumus boldus and extracts of meadowsweet Spiraea ulmaria. The invention applies in particular to preventing or treating or to assisting with the control of microbial infections.


The invention relates to a packaging comprising: a rigid shell that can be deformed by having a user apply pressure, said shell forming a storage space (1) containing a liquid or pasty substance; a breakage area (6) for releasing an applicator (3) for ejecting the liquid or pasty substance from said packaging; and a gripping area (5) including an escape path (7) for said liquid or pasty substance, the escape path being naturally closed when the user applies no pressure such that the liquid or pasty substance is prevented from being discharged after opening the packaging


The invention relates to a composition comprising revivable dehydrated micro-organisms. The invention is characterised in that it further comprises particles at least 50% of which have a mean diameter greater than 250 m. The invention is applicable, in particular, to human or veterinary pharmaceuticals, to dietetics or to food products.


The invention relates to a product for oral administration intended for a pet, comprising extracts of punica granatum (pomegranate). The invention is characterised in that the invention further comprises at least two additional antioxidant compounds chosen from: soya isoflavone extracts; L-carnitine; and taurine.


Patent
Virbac Sa | Date: 2011-05-09

The invention relates to a composition for topical application as well as the use of such a composition. The invention is characterised in that it comprises at least one first and one second mono- or oligosaccharide, each of said first and second mono- or oligosaccharides being capable of limiting the adhesion of microorganisms on the skin of warm-blooded animals with coats.


Grant
Agency: European Commission | Branch: H2020 | Program: RIA | Phase: SFS-01b-2014 | Award Amount: 10.52M | Year: 2015

SAPHIR aims to develop vaccine strategies effective against endemic pathogens responsible for high economic losses in livestock in order to strengthen the profitability of food animal systems, improve animal welfare and reduce xenobiotic usage in farming with a One Health perspective. SAPHIR will bring novel vaccine strategies to the market i) at short term, with several promising vaccines brought to demonstration (RTL6), ii) at long term, with cutting edge strategies brought at proof of concept (RTL3) and iii) in line with socio-economic requirements. SAPHIR has selected two representative pathogens of pigs (Porcine Reproductive and Respiratory Syndrome Virus and Mycoplasma hyopneumoniae), chickens (Eimeria and Clostridium perfringens) and cattle (Bovine Respiratory Syncytial Virus, Mycoplasma bovis) to develop generic vaccine approaches applicable to other pathogens. SAPHIR will issue i) knowledge of immune mechanisms of protection, ii) affordable, safe and multivalent vaccines with DIVA properties, iii) efficient adjuvants targeting dendritic cells, optimal formulations, new mucosal and skin delivery systems, a new generation of DNA vectors and viral replicon platforms for fostering an earlier and longer duration of immunity including the perinatal period, and iv) basal biomarkers of individual immuno-competence for future breeding strategies. The SAPHIR dissemination and training programme includes creation of an integrated health management website, launch of a Global Alliance for Veterinary Vaccines and organization of workshops directed at food animal system stakeholders. This will ensure optimal research translation of SAPHIR outputs to market and field applications. SAPHIR brings together interdisciplinary expertise from fourteen academic institutes including a Chinese partner, five SMEs and two pharmaceutical companies.

Loading Virbac SA collaborators
Loading Virbac SA collaborators